News
HUM
315.98
-3.66%
-12.00
U.S. RESEARCH ROUNDUP- Doximity, Monster Beverage, ServiceNow
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Doximity, Monster Beverage, ServiceNow and Chipotle Mexican Grill among those. Boeing, AT&T and Boeing Co among companies with target price increases and price cuts.
Reuters · 4h ago
HUMANA INC <HUM.N>: JEFFERIES CUTS TARGET PRICE TO $365 FROM $381
Reuters · 6h ago
HUMANA INC <HUM.N>: RBC CUTS TARGET PRICE TO $353 FROM $415
Reuters · 6h ago
HUMANA INC <HUM.N>: STEPHENS CUTS TARGET PRICE TO $350 FROM $395
Reuters · 6h ago
HUMANA INC <HUM.N>: OPPENHEIMER CUTS TARGET PRICE TO $370 FROM $415
Reuters · 6h ago
Humana’s Buy Rating Affirmed Amidst Long-Term Growth Potential and Competitive Positioning
TipRanks · 9h ago
Why Humana Stock Withered on Wednesday
Humana's first-quarter revenue was up 14% to $29.6 billion. The company's stock closed down almost 4% on Wednesday. The S&P 500 index was also down on the day. The health insurer reported better-than-expected numbers. Humana is a provider of Medicare Advantage plans.
The Motley Fool · 11h ago
Molina Healthcare beats profit estimates aided by higher premiums
Molina Healthcare beats profit estimates aided by higher premiums in its government-backed Medicaid insurance plans for people with low income. The company posted adjusted profit of $5.73 per share for first-quarter. Molina's medical cost ratio was 88.5%, above Wall Street estimates of 88.2%.
Reuters · 13h ago
Humana Inc. Form 10-Q for the Quarter Ended March 31, 2024
Press release · 15h ago
Humana Withdraws Its Already Lowered 2025 Profit Guidance
Humana Inc. Said the company withdrew its already lowered 2025 profit forecast. The company cited disappointing government Medicare Advantage reimbursement rates. Humana’s medical benefit ratio rose to 88.9% in the first quarter. The insurance firm said the final MA rate notice is not sufficient to address the current medical cost trend environment.
Benzinga · 16h ago
Stocks Fluctuate on Rising Bond Yields
NASDAQ · 17h ago
Noteworthy Wednesday Option Activity: HUM, GD, ALGN
NASDAQ · 17h ago
BUZZ-U.S. STOCKS ON THE MOVE-Globe Life, EQT, Ribbon Communications
Wall Street's main indexes pared early gains to trade lower on Wednesday. Dow Jones Industrial Average .DJI was down 0.11% at 38,460.49. Top three S&P 500 percentage gainers: Tesla Inc, Hasbro and Visa. Positive earnings across several sectors and rising Treasury yields pressured equities.
Reuters · 17h ago
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
The S&P 500 fell 0.4% in midday trading in New York. The yield on the 30-year Treasury bond has surged to 4.79%, the highest level since early November. The Japanese yen tumbled to the lowest level since June 1990. Tesla Inc. Posted lower-than-expected results last quarter, but shares rose 10%.
Benzinga · 17h ago
Stocks Lower on Rising Bond Yields
NASDAQ · 18h ago
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
NASDAQ · 18h ago
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
NASDAQ · 18h ago
BUZZ-U.S. STOCKS ON THE MOVE-MSCI, Globe Life, EQT Corp
The Nasdaq outpaced Wall Street peers on Wednesday. Tesla leads gains among megacap stocks after its quarterly results. The Dow Jones Industrial Average was down 0.35% at 38,368.64. The top three S&P 500 percentage gainers were Hasbro and Texas Instruments.
Reuters · 18h ago
Stocks Settle Mixed on Rising Bond Yields and Tech Strength
US stock indexes on Wednesday settled mixed, with the S&P 500 and Nasdaq 100 posting 1-week highs. Strength in technology stocks was supportive of the overall market, but rising bond yields pressured stocks. Tesla rose more than +12% despite reporting weaker-than-expected Q1 earnings. Q1 corporate earnings take center stage this week with 180 companies scheduled to report.
Barchart · 19h ago
Humana Earlier Said "Our 2025 Adj. EPS Growth Outlook Will Be Impacted By Several Variables To Which We Will Not Have Clear Visibility Until Later This Year; We Believe It Is Prudent To Provide More Specific Guidance For 2025 Once We Have Greater Clarity; We No Longer Believe $6 To $10 Of Adj. EPS Growth Is The Appropriate Target Range For 2025"
Benzinga · 19h ago
More
Webull provides a variety of real-time HUM stock news. You can receive the latest news about Humana through multiple platforms. This information may help you make smarter investment decisions.
About HUM
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.